Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab Announces Strategic Partnership And Global License Agreement With Medilink Therapeutics For A Next Generation Antibody-Drug Conjugate Program In Oncology

Zai Lab Ltd  9688.HK :
    * ZAI LAB ANNOUNCES STRATEGIC PARTNERSHIP AND GLOBAL LICENSE
AGREEMENT WITH MEDILINK THERAPEUTICS FOR A NEXT GENERATION
ANTIBODY-DRUG CONJUGATE PROGRAM IN ONCOLOGY
    * ZAI LAB LTD - UNDER TERMS OF AGREEMENT, MEDILINK WILL BE
ELIGIBLE TO RECEIVE CERTAIN UPFRONT FEES AND DEVELOPMENT
    * ZAI LAB LTD - UNDER TERMS, MEDILINK WILL BE ELIGIBLE TO
RECEIVE
SALES-BASED MILESTONE PAYMENTS AS WELL AS TIERED ROYALTIES ON
GLOBAL ANNUAL NET SALES
    * ZAI LAB LTD - UNDER TERMS, MEDILINK WILL BE ELIGIBLE TO
RECEIVE
POTENTIAL THIRD-PARTY SUBLICENSING PAYMENTS
    * ZAI LAB LTD - ZAI LAB WILL BE RESPONSIBLE FOR ALL
DEVELOPMENT
AND COMMERCIALIZATION ACTIVITIES GLOBALLY

Source text for Eikon:  ID:nGNX9NZyng 
Further company coverage:  9688.HK

Recent news on Zai Lab

See all news